No definition available.
Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced
PHLEBI_THROMBOP_LOWER_EXTREMITI_UNSPE
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
349 |
4. Check minimum number of eventsNone |
349 |
5. Include endpointsNone |
349 |
6. Filter based on genotype QC (FinnGen only) |
309 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced
based on the number of shared cases.
Similar with more cases:
- Venous thromboembolism
- Cardiovascular diseases
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (not available in FinRegistry).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 309 | 171 | 138 |
| Unadjusted period prevalence (%) | 0.06 | 0.06 | 0.06 |
| Median age at first event (years) | 50.77 | 47.12 | 55.30 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 314
- Matched controls
- 3140
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
+∞
307.7
314
66
B01AA03
ATC
warfarin; systemic
12.9
115.1
220
483
B01AB04
ATC
dalteparin; parenteral
13.4
68.0
71
67
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
11.1
37.4
42
43
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
9.6
36.6
46
55
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
8.2
29.6
42
58
B01AB05
ATC
enoxaparin; parenteral
3.3
23.7
158
743
M79.6
ICD-10 Finland
Pain in limb
2.9
18.7
181
1008
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
3.6
17.6
69
229
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.5
17.2
69
232
I82.9
ICD-10 Finland
Embolism and thrombosis of unspecified vein
12.7
16.4
29
25
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
12.7
15.4
27
23
4511A
ICD-9 Finland
Phlebitis and thrombophlebitis, Of deep vessels of lower extremities
20.4
14.4
21
11
I80.9
ICD-10 Finland
Phlebitis and thrombophlebitis of unspecified site
20.4
14.4
21
11
K94
ICPC
Phlebitis/thrombophlebitis
10.8
13.2
25
25
D68.8
ICD-10 Finland
Other specified coagulation defects
17.3
11.8
18
11
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.7
11.4
38
112
A46
ICD-10 Finland
Erysipelas
2.7
11.3
70
299
I87.0
ICD-10 Finland
Postthrombotic syndrome
29.2
10.8
14
5
ZXE00
NOMESCO Finland
One hour or less
2.2
10.5
140
839
N02AX02
ATC
tramadol; systemic, rectal
2.2
10.5
164
1047
J01DA01
ATC
[U] cefalexin
2.3
10.1
217
1562
ZYC01, ,
SPAT
3.1
9.7
44
157
D01AC02
ATC
miconazole; topical
3.2
9.3
38
128
K78
ICPC
Atrial fibrillation/flutter
3.0
9.0
43
158
J45.1
ICD-10 Finland
Nonallergic asthma
3.3
9.0
36
119
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
8.2
8.5
18
23
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
7.4
8.4
19
27
D68.2
ICD-10 Finland
Hereditary deficiency of other clotting factors
34.3
8.1
10
*
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
8.8
7.9
16
19
M10.9
ICD-10 Finland
Gout, unspecified
3.1
7.6
34
120
K93
ICPC
Pulmonary embolism
10.4
7.6
14
14
ZXD05
NOMESCO Finland
Urgent procedure
2.0
7.4
107
643
R60.0
ICD-10 Finland
Localized oedema
2.4
7.3
55
255
R51
ICD-10 Finland
Headache
3.8
6.9
21
58
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.4
6.9
25
78
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.4
6.8
50
229
C03CA01
ATC
furosemide; systemic
1.9
6.7
137
919
A02BC01
ATC
omeprazole; systemic
1.9
6.6
100
607
J01MA02
ATC
ciprofloxacin; systemic
1.9
6.6
136
915
A02BA04
ATC
nizatidine; systemic
2.7
6.5
35
138
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
6.4
121
789
J01DB01
ATC
cefalexin; oral
2.1
6.4
255
2107
J01FF01
ATC
clindamycin; systemic
1.9
6.3
95
574
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
6.3
64
335
R03BB04
ATC
tiotropium bromide; inhalant
2.4
6.1
44
200
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
196
1384
2.11
9.14
44.1
15.4
1.68
1.29
inr
10.30
176
1152
107
610
2.14
8.78
2.3
1.7
1.61
1.43
mg/l
0.21
79
499
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
28
80
3.74
8.74
5.3
2.0
0.34
0.36
iu/ml
0.12
17
39
6
334
0.16
7.90
4.2
5.0
33.33
32.71
%
—
6
208
122
824
1.79
5.61
3.6
3.5
0.53
0.47
e6/l
0.15
95
611
47
235
2.18
5.19
4.0
4.4
1.22
1.22
mmol/l
0.21
38
207
63
354
1.98
5.10
2.1
1.9
—
—
—
0
0
55
295
2.05
5.06
4.8
3.9
—
—
—
0
0
9
10
9.22
4.81
1.7
3.3
1375.44
775.60
u/ml
—
9
10
164
1240
1.68
4.81
6.2
4.7
34.33
35.10
g/l
0.90
152
1168
50
265
2.05
4.75
2.1
2.5
26.15
31.73
u/l
0.92
41
218
60
343
1.93
4.60
8.3
7.0
2.27
1.17
mmol/l
1.18
55
276
60
348
1.90
4.40
8.3
6.9
11.09
11.91
kpa
0.70
60
337
60
348
1.90
4.40
8.4
6.9
5.35
5.12
kpa
1.07
60
336
122
872
1.65
4.33
4.4
3.4
30.45
30.85
u/l
0.06
114
825
63
376
1.85
4.22
2.1
1.8
—
—
—
0
0
11
328
0.31
3.92
7.2
8.0
—
—
—
0
0
196
1616
1.57
3.58
6.9
4.9
6.80
6.78
mmol/l
0.05
189
1543
15
52
2.98
3.51
1.4
1.5
—
—
—
0
0
15
52
2.98
3.51
1.4
1.5
—
—
—
0
0
75
500
1.66
3.38
2.1
1.9
—
—
—
0
0
70
460
1.67
3.33
2.9
3.3
3.76
2.42
e6/l
0.34
34
237
74
494
1.65
3.32
2.7
3.1
1.26
1.10
e6/l
0.15
37
272
103
746
1.57
3.30
2.5
2.2
2.93
3.01
mg/l
0.11
88
645
12
34
3.63
3.23
1.0
1.0
—
—
—
0
0
97
698
1.56
3.18
3.0
3.0
373.94
349.43
umol/l
1.23
88
602
30
154
2.05
3.12
10.8
8.3
15.97
15.56
%
0.34
30
149
82
571
1.59
3.09
5.6
4.1
224.00
253.67
ng/l
0.08
73
480
50
306
1.75
3.07
3.1
2.9
12.34
7.49
umol/l
0.52
44
277
149
1195
1.47
2.85
3.6
3.0
101.35
138.19
ug/l
2.12
136
1104
6
10
6.09
2.71
3.5
7.9
—
—
—
0
0
126
990
1.46
2.63
3.5
3.3
2110.03
1544.63
ng/l
0.51
108
840
47
296
1.69
2.61
5.3
3.5
2.23
2.01
mmol/l
0.14
39
243
69
488
1.53
2.39
3.5
2.6
11.29
12.41
umol/l
0.82
64
457
176
1490
1.41
2.36
11.1
10.1
4.53
4.08
e9/l
1.56
160
1295
47
305
1.64
2.34
5.4
3.5
6.15
5.71
kpa
1.65
47
294
173
1464
1.40
2.30
7.4
6.8
13.53
11.45
umol/l
0.62
167
1398
10
35
2.92
2.23
1.4
1.1
18.80
4.35
u/ml
—
5
17
82
610
1.47
2.22
2.7
3.0
2.47
2.46
mmol/l
0.34
75
539
5
9
5.62
2.22
2.0
2.8
89.20
97.33
%
—
5
9
169
1434
1.39
2.16
4.4
4.3
20.87
10.88
estimate
0.18
55
322
170
1445
1.38
2.15
4.4
4.4
0.00
1.01
estimate
0.50
51
297
227
2027
1.43
2.14
11.5
8.4
83.19
80.49
u/l
0.29
220
1912
116
926
1.40
2.13
3.3
3.3
6.76
7.23
mmol/l
0.58
105
771
34
209
1.70
2.08
1.5
1.6
—
—
—
0
0
155
1306
1.37
2.03
9.4
6.1
1.21
1.21
mmol/l
0.13
145
1196
167
1425
1.37
2.01
4.4
4.3
0.00
0.00
estimate
-0.00
51
312
116
934
1.38
2.00
4.4
4.1
16.23
10.36
mg/mmol
0.42
82
593
122
992
1.38
1.98
3.2
3.4
2.34
2.35
mmol/l
0.63
113
896
106
855
1.36
1.78
1.8
1.7
16.58
21.26
nmol/l
4.53
94
705
30
188
1.66
1.73
6.8
6.0
26.20
24.33
mmol/l
1.29
30
180
5
14
3.61
1.62
1.0
1.1
—
—
—
0
0
143
1237
1.29
1.40
2.5
2.2
90.57
95.00
pmol/l
0.69
85
642
7
29
2.45
1.40
1.3
1.4
—
—
—
0
0
139
1199
1.29
1.39
2.9
2.5
73.93
79.00
nmol/l
1.55
130
1066
9
42
2.18
1.35
1.2
1.4
—
—
—
0
0
27
177
1.57
1.34
1.6
1.8
—
—
—
0
0
0
41
0.00
1.32
0.0
3.0
—
19.65
—
0
17
9
44
2.08
1.28
1.2
1.5
—
—
—
0
0
14
78
1.83
1.23
7.9
2.5
7.51
7.97
kpa
0.43
14
78
20
127
1.61
1.14
3.1
3.3
460.33
2782.99
u/ml
0.98
12
111
210
1933
1.26
1.13
4.9
4.2
15.28
14.93
pmol/l
0.84
194
1742
129
1130
1.24
1.08
5.6
4.4
37.37
43.10
ng/l
0.13
86
872
5
23
2.19
0.98
1.0
1.1
—
—
—
0
0
10
54
1.88
0.97
1.2
1.6
—
—
—
0
0
7
36
1.97
0.97
1.3
1.4
—
—
—
0
0
159
1436
1.22
0.96
9.9
6.8
1.22
1.21
mmol/l
0.41
129
1230
11
62
1.80
0.95
4.6
2.9
12.67
9.75
pmol/l
0.25
11
62
9
52
1.75
0.93
1.4
1.1
25.17
32.44
u/l
—
9
42
149
1341
1.21
0.92
3.1
2.8
—
—
—
0
0
11
63
1.77
0.91
1.1
1.2
—
—
—
0
0
102
888
1.22
0.88
2.3
2.1
198.62
180.38
u/l
0.10
95
839
6
30
2.02
0.87
3.3
3.5
28.33
36.86
u/ml
—
6
30
6
30
2.02
0.87
1.0
1.0
—
—
—
0
0
11
64
1.74
0.87
1.3
1.4
—
—
—
0
0
13
80
1.65
0.86
1.8
1.6
—
—
—
0
0
6
31
1.95
0.85
1.2
1.3
—
—
—
0
0
6
31
1.95
0.85
1.0
1.3
—
—
—
0
0
17
114
1.52
0.81
2.2
2.6
—
—
—
0
0
9
149
0.59
0.81
6.9
3.1
32.04
32.75
u/ml
—
9
143
13
82
1.61
0.79
1.2
1.5
—
—
—
0
0
0
26
0.00
0.79
0.0
1.8
—
2.55
—
0
11
13
83
1.59
0.76
1.2
1.5
—
—
—
0
0
12
75
1.62
0.76
6.5
3.2
1.50
1.83
index
—
6
46
15
100
1.53
0.74
1.2
1.2
—
—
—
0
0
93
819
1.19
0.70
5.3
4.4
0.00
0.01
estimate
0.50
50
286
53
445
1.23
0.65
1.4
1.3
3.79
10.05
u/ml
1.13
20
180
13
87
1.52
0.64
1.3
1.3
—
—
—
0
0
33
262
1.29
0.64
4.2
3.0
4.05
4.32
kpa
0.50
33
251
15
105
1.45
0.61
1.1
1.0
—
—
—
0
0
257
2477
1.21
0.61
28.0
17.9
23.28
24.89
mg/l
0.43
227
2064
241
2310
1.19
0.61
6.3
5.3
2.04
1.95
mu/l
0.41
226
2105
0
20
0.00
0.60
0.0
4.0
—
0.80
—
0
20
133
1222
1.15
0.59
3.5
2.8
—
—
estimate
—
0
0
21
158
1.35
0.59
5.2
3.4
4.71
2.15
mmol/l
1.30
14
122
171
1602
1.15
0.57
4.4
3.2
65.74
49.33
u/l
1.04
159
1495
5
86
0.57
0.57
1.2
1.3
—
—
—
0
0
21
160
1.33
0.55
2.1
1.4
—
—
—
0
0
14
103
1.38
0.46
7.2
2.6
27.61
25.02
mmol/l
1.02
14
103
80
882
0.88
0.45
6.4
5.9
2.27
2.85
ug/l
0.50
71
778
202
1932
1.13
0.44
6.3
4.6
15.40
13.46
mm/h
0.83
190
1781
38
323
1.20
0.44
3.9
4.4
35.98
41.28
ug/l
0.05
31
269
41
353
1.19
0.42
1.7
1.5
—
—
—
0
0
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
69
621
1.14
0.41
2.1
1.8
477.83
442.79
pmol/l
0.33
54
514
46
524
0.86
0.40
2.8
3.5
0.79
0.79
ug/l
0.00
31
351
114
1060
1.12
0.40
2.0
2.0
1.40
1.30
mmol/l
0.86
95
882
64
711
0.87
0.40
4.6
4.9
21.61
22.26
%
0.14
30
366
8
61
1.32
0.40
2.3
1.4
—
—
—
0
0
64
578
1.13
0.36
1.4
1.3
2.29
1.58
u/ml
0.18
25
153
9
71
1.28
0.36
1.2
1.4
—
—
—
0
0
15
117
1.30
0.36
1.6
1.6
—
—
—
0
0
60
542
1.13
0.34
1.9
1.8
1198.10
1139.05
nmol/l
0.19
48
415
58
636
0.89
0.30
4.1
4.5
1.02
1.02
kg/l
0.13
27
435
7
57
1.23
0.29
1.1
1.3
—
—
—
0
0
53
483
1.12
0.27
1.5
1.3
10.64
41.44
iu/ml
5.66
11
162
26
225
1.17
0.27
3.3
3.1
66.54
63.22
ml/min/173m2
0.15
12
103
17
200
0.84
0.23
2.0
2.1
3.19
3.35
ratio
0.22
12
169
38
344
1.12
0.22
1.6
1.4
—
—
—
0
0
5
41
1.22
0.22
3.2
4.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.7
—
42.48
—
0
12
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
2.6
—
—
—
0
0
20
228
0.87
0.19
1.3
1.4
—
—
—
0
0
242
2378
1.08
0.19
8.1
6.9
41.45
40.05
mmol/mol
1.51
231
2230
17
147
1.17
0.18
3.8
3.3
26.74
24.71
mmol/l
1.10
17
141
114
1100
1.06
0.16
5.0
4.3
0.00
0.02
estimate
0.96
44
262
9
81
1.11
0.15
1.0
1.2
—
—
—
0
0
9
82
1.10
0.15
1.0
1.2
—
—
—
0
0
241
2441
0.95
0.13
5.3
5.4
4.44
4.56
mmol/l
1.00
228
2259
68
651
1.06
0.12
2.8
2.4
—
—
—
0
0
229
2320
0.95
0.12
4.3
4.4
1.39
1.25
mmol/l
2.52
216
2114
13
147
0.88
0.11
1.8
1.9
3.33
3.42
mmol/l
—
7
114
240
2428
0.95
0.11
5.1
5.2
1.41
1.48
mmol/l
2.11
227
2229
15
134
1.13
0.11
1.7
1.8
—
—
—
0
0
246
2484
0.96
0.09
6.7
6.2
2.55
2.63
mmol/l
0.67
233
2289
6
56
1.07
0.08
2.3
3.6
15.83
31.29
u/ml
—
6
56
237
2393
0.96
0.08
28.4
17.7
75.72
75.68
ml/min/173m2
0.01
232
2239
5
63
0.79
0.08
1.6
1.5
—
—
—
0
0
6
72
0.83
0.07
1.7
1.5
—
—
—
0
0
257
2588
0.96
0.07
17.3
12.7
26.38
24.29
u/l
1.38
250
2516
18
169
1.07
0.05
4.7
4.2
48.54
47.62
%
0.06
18
163
242
2431
0.98
0.03
5.9
5.4
6.29
6.02
mmol/l
2.51
225
2211
79
782
1.01
0.01
5.0
3.7
0.02
0.11
estimate
0.37
44
246
11
114
0.96
0.00
1.2
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
3.7
—
10.78
—
0
9
0
9
0.00
0.00
0.0
3.7
—
4.68
—
0
9
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
5
51
0.98
0.00
1.6
1.5
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
7.34
—
0
5
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
6
68
0.88
-0.00
1.2
1.2
—
—
—
0
0
6
60
1.00
-0.00
2.0
1.9
36.67
45.31
nmol/l
—
6
55
7
76
0.92
-0.00
1.3
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
6
61
0.98
-0.00
1.5
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (not available in FinRegistry).
Relationships between endpoints
↥Index endpoint: PHLEBI_THROMBOP_LOWER_EXTREMITI_UNSPE – Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced
GWS hits: 1
This endpoint is excluded (not available in FinRegistry).